Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Am J Clin Oncol. 2020 Jan;43(1):64–68. doi: 10.1097/COC.0000000000000628

Table 2:

Multivariate Cox Proportional Hazard Regression Model for Overall Survival

Variable Adjusted Hazard Ratio (95% CI) p-value
Treatment with anti-VEGF antibody 0.62 (0.28–0.99) 0.049
Age 0.92 (0.82–1.03) 0.16
Sex 0.86 (0.55–1.34) 0.51
Race/Ethnicity
1) Blacks vs. Non-Hispanic Whites 1.25 (0.65–2.39) 0.48
2) Hispanic Whites vs. Non-Hispanic Whites 1.28 (0.65–2.53) 0.47
3) Blacks vs. Hispanic Whites 0.97 (0.60–1.57) 0.92
ECOG Performance Status 1.34 (0.97–1.85) 0.07
Total Number of Metastases 1.19 (1.05–1.35) 0.005
EGFR mutation status (ex19del/ex21 L858R) 0.33 (0.14–0.79) 0.01